Integrated Clinical Development Services
Our in-depth knowledge of global regulatory submission requirements allows us to guide clients through the complexities of clinical trial approvals and regulatory pathways.
Comprehensive Regulatory Support
The Micron Group provides comprehensive regulatory affairs support for the preparation of applications including Investigational New Drug (IND) applications, New Drug Applications (NDAs), and Biologics License Applications (BLAs).
Expert guidance through every regulatory milestone — from early-phase planning to final submission.
Expert Clinical and Regulatory Writing
We provide clinical and regulatory medical writing services throughout the product development lifecycle, from preclinical through Phase I to Phase IV clinical trials.
Our regulatory writing capabilities include:
Investigator Brochures,
Clinical Trial Protocols,
Clinical Study Reports (CSRs),
Regulatory Authority Response Documents,
Patient Narratives, and Safety Reports, including Periodic Benefit-Risk Evaluation Reports (PBRERs).
Integrated Clinical Development